Renale Ko-Morbidität nach Transplantation 
solider Organe

Literatur
1 EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417
2 Backman L, Reisaeter AV, Wramner L et al. Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus. Clin Transplant 2006; 20: 336-339
3 Barri YM, Sanchez EQ, Jennings LW et al. Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl 2009; 15: 475-483
4 Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 1995; 55: 617-623
5 Bloom RD, Reese PP. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol 2007; 18: 3031-3041
6 Bokenkamp A, van Wijk JA, Lentze MJ et al. Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations. Clin Chem 2002; 48: 1123-1126
7 Boyer O, Le Bidois J, Dechaux M et al. Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil. Transplantation 2005; 79: 1405-1410
8 Boyle JM, Moualla S, Arrigain S et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis 2006; 48: 787-796
9 Cabezuelo JB, Ramirez P, Rios A et al. Risk factors of acute renal failure after liver transplantation. Kidney Int 2006; 69: 1073-1080
10 Castroagudin JF, Molina E, Romero R et al. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction. Liver Transpl 2009; 15: 1792-1797
11 Charlton MR, Wall WJ, Ojo AO et al. Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl 2009; 15: 1-34
12 Cholongitas E, Shusang V, Marelli L et al. Review article: renal function assessment in cirrhosis – difficulties and alternative measurements. Aliment Pharmacol Ther 2007; 26: 969-978
13 Clajus C, Hanke N, Gottlieb J et al. Renal comorbidity after solid organ and stem cell transplantation. Am J Transplant 2012; 12: 1691-1699
14 Creput C, Blandin F, Deroure B et al. Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation. Liver Transpl 2007; 13: 1004-1010
15 Davis CL, Feng S, Sung R et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant 2007; 7: 1702-1709
16 Fan Y, Xiao YB, Weng YG. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. Transplantation proceedings 2009; 41: 1821-1824
17 Fioretto P, Kim Y, Mauer M. Diabetic nephropathy as a model of reversibility of established renal lesions. Curr Opin Nephrol Hypertens 1998; 7: 489-494
18 Fioretto P, Steffes MW, Mihatsch MJ et al. Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipients. Kidney Int 1995; 48: 489-495
19 Fisher NC, Nightingale PG, Gunson BK et al. Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation 1998; 66: 59-66
20 Flechner SM. Reviewing the evidence for de novo immunosuppression with sirolimus. Transplant Proc 2008; 40: 25-28
21 Groetzner J, Kaczmarek I, Schulz U et al. Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure. Transplantation 2009; 87: 726-733
22 Haas M, Kain R, Mayer G et al. Heart transplantation or combined heart/kidney transplantation? Even one renal biopsy may fool you. Nephrol Dial Transplant 1999; 14: 1014-1015
23 Herlenius G, Fistouris J, Olausson M et al. Early renal function post-liver transplantation is predictive of progressive chronic kidney disease. Scand J Gastroenterol 2008; 43: 344-349
24 Ishani A, Erturk S, Hertz MI et al. Predictors of renal function following lung or heart-lung transplantation. Kidney Int 2002; 61: 2228-2234
25 Karie-Guigues S, Janus N, Saliba F et al. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study. Liver Transpl 2009; 15: 1083-1091
26 Kim JY, Akalin E, Dikman S et al. The variable pathology of kidney disease after liver transplantation. Transplantation 2010; 89: 215-221
27 Lindelow B, Bergh CH, Herlitz H et al. Predictors and evolution of renal function during 9 years following heart transplantation. J Am Soc Nephrol 2000; 11: 951-957
28 Mehra MR, Kobashigawa J, Starling R et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant 2006; 25: 1024-1042
29 O'Riordan A, Wong V, McCormick PA et al. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant 2006; 21: 2630-2636
30 Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940
31 Orlando R, Mussap M, Plebani M et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002; 48: 850-858
32 Poge U, Gerhardt T, Stoffel-Wagner B et al. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant 2006; 21: 660-664
33 Risch L, Herklotz R, Blumberg A et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001; 47: 2055-2059
34 Rocha PN, Rocha AT, Palmer SM et al. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality. Am J Transplant 2005; 5: 1469-1476
35 Rothenburger M, Zuckermann A, Bara C et al. Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference. J Heart Lung Transplant 2007; 26: 305-311
36 Rubel JR, Milford EL, McKay DB et al. Renal insufficiency and end-stage renal disease in the heart transplant population. J Heart Lung Transplant 2004; 23: 289-300
37 Schlitt HJ, Barkmann A, Boker KH et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet 2001; 357: 587-591
38 Schwarz A, Haller H, Schmitt R et al. Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues. Am J Transplant 2010; 10: 2017-2025
39 Shemesh O, Golbetz H, Kriss JP et al. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28: 830-838
40 Skluzacek PA, Szewc RG, Nolan CR et al. Prediction of GFR in liver transplant candidates. Am J Kidney Dis 2003; 42: 1169-1176
41 Soccal PM, Gasche Y, Favre H et al. Improvement of drug-induced chronic renal failure in lung transplantation. Transplantation 1999; 68: 164-165
42 Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 2009; 20: 2305-2313
43 White CA, Akbari A, Doucette S et al. Estimating glomerular filtration rate in kidney transplantation: is the new chronic kidney disease epidemiology collaboration equation any better?. Clinical chemistry 2010; 56: 474-477
44 Wilkinson A, Pham PT. Kidney dysfunction in the recipients of liver transplants. Liver Transpl 2005; S47-51